Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $6.9200 (8.81%) ($6.9200 - $6.9200) on Mon. May. 2, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.63% (three month average) | RSI | 31 | Latest Price | $6.9200(8.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -9.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(47%) IBB(44%) ARKK(43%) ARKG(42%) XAR(41%) | Factors Impacting ATRA price | ATRA will decline at least -2.315% in a week (0% probabilities). VIXM(-39%) VXX(-26%) UNG(-17%) USO(-11%) TLT(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.315% (StdDev 4.63%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-15.85(-329.05%) | Resistance Level | $7.84 | 5 Day Moving Average | $6.66(3.9%) | 10 Day Moving Average | $7.07(-2.12%) | 20 Day Moving Average | $7.84(-11.73%) | To recent high | -55.8% | To recent low | 8.8% | Market Cap | $514m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |